NRG1 fusions in breast cancer

BACKGROUND: NRG1 gene fusions may be clinically actionable, since cancers carrying the fusion transcripts can be sensitive to tyrosine kinase inhibitors. The NRG1 gene encodes ligands for the HER2(ERBB2)-ERBB3 heterodimeric receptor tyrosine kinase, and the gene fusions are thought to lead to autocr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Breast Cancer Res
Huvudupphovsmän: Howarth, Karen D., Mirza, Tashfina, Cooke, Susanna L., Chin, Suet-Feung, Pole, Jessica C., Turro, Ernest, Eldridge, Matthew D., Garcia, Raquel Manzano, Rueda, Oscar M., Boursnell, Chris, Abraham, Jean E., Caldas, Carlos, Edwards, Paul A. W.
Materialtyp: Artigo
Språk:Inglês
Publicerad: BioMed Central 2021
Ämnen:
Research Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788813/
https://ncbi.nlm.nih.gov/pubmed/33413557
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-020-01377-5
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk